Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Fenton, Sarah
Assistant Professor
Bio
Dr. Sarah Fenton has a clinical focus on the management of genitourinary cancers including prostate, bladder, kidney and testicular cancer. Her research focuses on the identification of novel therapeu... [more]